The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 12, 2022

Filed:

May. 30, 2019
Applicant:

University of Pittsburgh—of the Commonwealth System of Higher Education, Pittsburgh, PA (US);

Inventors:

Jianhua Luo, Wexford, PA (US);

Zhanghui Chen, Huzhou, CN;

Yanping Yu, Wexford, PA (US);

George Michalopoulos, Pittsburgh, PA (US);

Joel B. Nelson, Pittsburgh, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/45 (2006.01); C12Q 1/6886 (2018.01); A61P 35/00 (2006.01); A61K 31/4545 (2006.01); A61K 31/5377 (2006.01); A61N 7/00 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); A61K 31/4545 (2013.01); A61K 31/5377 (2013.01); A61N 7/00 (2013.01); A61P 35/00 (2018.01); C12N 15/1137 (2013.01); C12N 2310/14 (2013.01); C12Q 2600/106 (2013.01);
Abstract

The present invention relates to methods of treating cancer patients carrying one or more specific fusion genes. It is based, at least in part, on the discovery that the protein encoded by the MAN2A1-FER fusion gene exhibits kinase activity and the use of tyrosine kinase inhibitors targeting MAN2A1-FER in a cancer other than prostate, for example hepatocellular cancer, led to dramatic improvement of survival of animals xenografted with the cancer.


Find Patent Forward Citations

Loading…